These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 16052609)

  • 1. C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist.
    Bao L; Osawe I; Puri T; Lambris JD; Haas M; Quigg RJ
    Eur J Immunol; 2005 Aug; 35(8):2496-506. PubMed ID: 16052609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C5a receptor deficiency attenuates T cell function and renal disease in MRLlpr mice.
    Wenderfer SE; Ke B; Hollmann TJ; Wetsel RA; Lan HY; Braun MC
    J Am Soc Nephrol; 2005 Dec; 16(12):3572-82. PubMed ID: 16207826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
    Steinmetz OM; Turner JE; Paust HJ; Lindner M; Peters A; Heiss K; Velden J; Hopfer H; Fehr S; Krieger T; Meyer-Schwesinger C; Meyer TN; Helmchen U; Mittrücker HW; Stahl RA; Panzer U
    J Immunol; 2009 Oct; 183(7):4693-704. PubMed ID: 19734217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
    Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B
    J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C5a alters blood-brain barrier integrity in experimental lupus.
    Jacob A; Hack B; Chiang E; Garcia JG; Quigg RJ; Alexander JJ
    FASEB J; 2010 Jun; 24(6):1682-8. PubMed ID: 20065106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice.
    Hasegawa H; Kohno M; Sasaki M; Inoue A; Ito MR; Terada M; Hieshima K; Maruyama H; Miyazaki J; Yoshie O; Nose M; Fujita S
    Arthritis Rheum; 2003 Sep; 48(9):2555-66. PubMed ID: 13130475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement component C5a permits the coexistence of pathogenic Th17 cells and type I IFN in lupus.
    Pawaria S; Ramani K; Maers K; Liu Y; Kane LP; Levesque MC; Biswas PS
    J Immunol; 2014 Oct; 193(7):3288-95. PubMed ID: 25149466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL/lpr mice.
    Inoue A; Hasegawa H; Kohno M; Ito MR; Terada M; Imai T; Yoshie O; Nose M; Fujita S
    Arthritis Rheum; 2005 May; 52(5):1522-33. PubMed ID: 15880599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amelioration of autoimmune nephritis by imatinib in MRL/lpr mice.
    Sadanaga A; Nakashima H; Masutani K; Miyake K; Shimizu S; Igawa T; Sugiyama N; Niiro H; Hirakata H; Harada M
    Arthritis Rheum; 2005 Dec; 52(12):3987-96. PubMed ID: 16320345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IK cytokine ameliorates the progression of lupus nephritis in MRL/lpr mice.
    Muraoka M; Hasegawa H; Kohno M; Inoue A; Miyazaki T; Terada M; Nose M; Yasukawa M
    Arthritis Rheum; 2006 Nov; 54(11):3591-600. PubMed ID: 17075801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of spontaneous B lymphocyte autoimmunity with adenovirus-encoded soluble TACI.
    Liu W; Szalai A; Zhao L; Liu D; Martin F; Kimberly RP; Zhou T; Carter RH
    Arthritis Rheum; 2004 Jun; 50(6):1884-96. PubMed ID: 15188365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular expression of the C5a anaphylatoxin receptor (C5aR): demonstration of C5aR on nonmyeloid cells of the liver and lung.
    Haviland DL; McCoy RL; Whitehead WT; Akama H; Molmenti EP; Brown A; Haviland JC; Parks WC; Perlmutter DH; Wetsel RA
    J Immunol; 1995 Feb; 154(4):1861-9. PubMed ID: 7836770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depletion of autoreactive plasma cells and treatment of lupus nephritis in mice using CEP-33779, a novel, orally active, selective inhibitor of JAK2.
    Lu LD; Stump KL; Wallace NH; Dobrzanski P; Serdikoff C; Gingrich DE; Dugan BJ; Angeles TS; Albom MS; Mason JL; Ator MA; Dorsey BD; Ruggeri BA; Seavey MM
    J Immunol; 2011 Oct; 187(7):3840-53. PubMed ID: 21880982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice.
    Matsumoto K; Watanabe N; Akikusa B; Kurasawa K; Matsumura R; Saito Y; Iwamoto I; Saito T
    Arthritis Rheum; 2003 Feb; 48(2):486-94. PubMed ID: 12571859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin disease is prevented but nephritis is accelerated by multiple pregnancies in autoimmune MRL/LPR mice.
    Kökény G; Godó M; Nagy E; Kardos M; Kotsch K; Casalis P; Bodor C; Rosivall L; Volk HD; Zenclussen AC; Hamar P
    Lupus; 2007; 16(7):465-77. PubMed ID: 17670844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of glomerular heparan sulphate domains in murine and human lupus nephritis.
    Rops AL; van den Hoven MJ; Bakker MA; Lensen JF; Wijnhoven TJ; van den Heuvel LP; van Kuppevelt TH; van der Vlag J; Berden JH
    Nephrol Dial Transplant; 2007 Jul; 22(7):1891-902. PubMed ID: 17550924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implication of allelic polymorphism of osteopontin in the development of lupus nephritis in MRL/lpr mice.
    Miyazaki T; Ono M; Qu WM; Zhang MC; Mori S; Nakatsuru S; Nakamura Y; Sawasaki T; Endo Y; Nose M
    Eur J Immunol; 2005 May; 35(5):1510-20. PubMed ID: 15832294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of C5a-C5aR interaction in sepsis.
    Guo RF; Riedemann NC; Ward PA
    Shock; 2004 Jan; 21(1):1-7. PubMed ID: 14676676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of monoclonal antibodies to assess expression of anaphylatoxin receptors in rat and murine models of lung inflammation.
    Tschernig T; Kiafard Z; Dibbert C; Neumann D; Zwirner J
    Exp Toxicol Pathol; 2007 Aug; 58(6):419-25. PubMed ID: 17544263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G-rich DNA suppresses systemic lupus.
    Patole PS; Zecher D; Pawar RD; Gröne HJ; Schlöndorff D; Anders HJ
    J Am Soc Nephrol; 2005 Nov; 16(11):3273-80. PubMed ID: 16176997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.